Eosinophils in Colorectal Neoplasms Associated with Expression of CCL11 and CCL24
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: A decrease in the number of tissue eosinophils is known to reflect the malignancy potential of neoplastic lesions and even prognosis. Increased levels of the chemokines CCL11 and CCL24 in serum and tissue are also known to have diagnostic value as serum tumor markers or prognostic factors. The aim of this study was to evaluate the correlation between the degree of tissue eosinophilia and the expression of these chemokines in the glandular and stromal cells of colorectal neoplastic lesions ranging from benign to malignant tumors. Methods: We counted the number of infiltrating eosinophils in neoplastic lesion tissue and we evaluated the expression of CCL11 and CCL24 in glandular cells and stromal cells by immunohistochemical staining. Results: The results showed that the number of eosinophils decreased significantly and the expression of CCL11 and CCL24 in glandular cells decreased with tumor progression, whereas the stromal expression of CCL11 and CCL24 appeared to increase. Conclusions: The discrepancy in CCL11 and CCL24 expression between glandular cells and stromal cells might shed light on how colorectal cancer evades the immune system, which would enable further development of immunotherapies that target these chemokines. Further research on eosinophil biology and the expression pattern of chemokines in tumor cells is needed.
Abstract
Background: A decrease in the number of tissue eosinophils is known to reflect the malignancy potential of neoplastic lesions and even prognosis. Increased levels of the chemokines CCL11 and CCL24 in serum and tissue are also known to have diagnostic value as serum tumor markers or prognostic factors. The aim of this study was to evaluate the correlation between the degree of tissue eosinophilia and the expression of these chemokines in the glandular and stromal cells of colorectal neoplastic lesions ranging from benign to malignant tumors. Methods: We counted the number of infiltrating eosinophils in neoplastic lesion tissue and we evaluated the expression of CCL11 and CCL24 in glandular cells and stromal cells by immunohistochemical staining. Results: The results showed that the number of eosinophils decreased significantly and the expression of CCL11 and CCL24 in glandular cells decreased with tumor progression, whereas the stromal expression of CCL11 and CCL24 appeared to increase. Conclusions: The discrepancy in CCL11 and CCL24 expression between glandular cells and stromal cells might shed light on how colorectal cancer evades the immune system, which would enable further development of immunotherapies that target these chemokines. Further research on eosinophil biology and the expression pattern of chemokines in tumor cells is needed.
참고문헌 (33)
- Rothenberg ME, "The eosinophil", Annu Rev Immunol, 24, pp.147~174 (2006)
- Adkinson NF, "Middleton’s allergy: principles and practice", pp.2009, Mosby
- Legrand F, "Human eosinophils exert TNFalpha and granzyme A-mediated tumoricidal activity toward colon carcinoma cells", J Immunol, 185, pp.7443~7451 (2010)
- Capron M, "Functions of eosinophil granulocytes: from anti-parasite immunity to anti-tumoral potential", Bull Acad Natl Med, 193, pp.339~346 (2009)
- Pretlow TP, "Eosinophil infiltration of human colonic carcinomas as a prognostic indicator", Cancer Res, 43, pp.2997~3000 (1983)
- Teo PZ, "Using the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20and MUC1", Cancer Immunol Immunother, 61, pp.2295~2309 (2012)
- Woerly G, "Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes", J Exp Med, 190, pp.487~495 (1999)
- Dorta RG, "Tumour-associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas", Histopathology, 41, pp.152~157 (2002)
- Fujii M, "Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma", Auris Nasus Larynx, 29, pp.175~181 (2002)
- Isaacson NH, "Eosinophilia in malignant tumors : its significance", Ann Intern Med, 25, pp.893~902 (1946)
- Goldsmith MM, "The importance of the eosinophil in head and neck cancer", Otolaryngol Head Neck Surg, 106, pp.27~33 (1992)
- Thompson AC, "Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx", Am J Surg, 168, pp.469~471 (1994)
- Nielsen HJ, "Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue", J Pathol, 189, pp.487~495 (1999)
- Fernández-Acenero MJ, "Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma", Cancer, 88, pp.1544~1548 (2000)
- Fisher ER, "Prognostic significance of eosinophils and mast cells in rectal cancer:findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01)", Hum Pathol, 20, pp.159~163 (1989)
- Oliveira DT, "Eosinophils may predict occult lymph node metastasis in early oral cancer", Clin Oral Investig, 16, pp.1523~1528 (2012)
- Kiziltas¸ S, "Does the severity of tissue eosinophilia of colonic neoplasms reflect their malignancy potential?", Turk J Gastroenterol, 19, pp.239~244 (2008)
- Polydorides AD, "Adenoma-infiltrating lymphocytes (AILs) are a potential marker of hereditary nonpolyposis colorectal cancer", Am J Surg Pathol, 32, pp.1661~1666 (2008)
- Moezzi J, "Stromal eosinophilia in colonic epithelial neoplasms", Am J Gastroenterol, 95, pp.520~523 (2000)
- Provost V, "CCL26", eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11, eotaxin-2, pp.J Leukoc Biol, 2013[DOI]
- Schaefer D, "Endothelial and epithelial expression of eotaxin-2 (CCL24) in nasal polyps", Int Arch Allergy Immunol, 140, pp.205~214 (2006)
- Menzies-Gow A, "Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers", J Immunol, 169, pp.2712~2718 (2002)
- Cheadle EJ, "Eotaxin-2 and colorectal cancer:a potential target for immune therapy", Clin Cancer Res, 13, pp.5719~5728 (2007)
- Erreni M, "Expression of chemokines and chemokine receptors in human colon cancer", Methods Enzymol, 460, pp.105~121 (2009)
- Cui G, "Immune microenvironmental shift along human colorectal adenoma-carcinoma sequence:is it relevant to tumor development, biomarkers and biotherapeutic targets?", Scand J Gastroenterol, 47, pp.367~377 (2012)
- Wågsäter D, "Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients", World J Surg Oncol, 5, pp.84~ (2007)
- Watanabe H, "Decreased expression of monocyte chemoattractant protein-1predicts poor prognosis following curative resection of colorectal cancer", Dis Colon Rectum, 51, pp.1800~1805 (2008)
- Agarwal M, "CCL11 (eotaxin-1): a new diagnostic serum marker for prostate cancer", Prostate, 73, pp.573~581 (2013)
- Monson JR, "Decreased interleukin-2 production in patients with gastrointestinal cancer", Br J Surg, 73, pp.483~486 (1986)
- King J, "High serum carcinoembryonic antigen concentration in patients with colorectal liver metastases is associated with poor cell-mediated immunity, which is predictive of survival", Br J Surg, 84, pp.1382~1385 (1997)
- Nielsen HJ, "Effect of ranitidine and low-dose interleukin-2 in vitro on NK-cell activity in peripheral blood from patients with liver metastases from colorectal cancer", Eur J Surg Oncol, 21, pp.526~530 (1995)
- Bovo G, "Pre-operative interleukin-2 immunotherapy induces eosinophilic infiltration in colorectal neoplastic stroma", Pathologica, 87, pp.135~138 (1995)
- Yoshida N, "Production and regulation of eotaxin-2", CCL24 in a differentiated human leukemic cell line, HT93, 2007, pp.30, 1826~1832
